Innocoll

Quick facts

Marketed products

• Bupivacaine Hydrochloride And Epinephrine · Ophthalmology
  Bupivacaine works by blocking nerve impulses to prevent pain signals from reaching the brain.
• XaraColl · Surgery/Wound Management
  XaraColl is a bioabsorbable collagen matrix that delivers chlorhexidine locally to promote hemostasis and reduce infection in surgical wounds.

Phase 3 pipeline

• Bupivacaine HCl collagen-matrix implant · Pain management / Surgery
  Bupivacaine HCl is released from a collagen matrix implant to provide local anesthesia at the surgical site.
• Bupivacaine HCl infiltration · Anesthesia/Pain Management
  Bupivacaine HCl is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Phase 2 pipeline

• gentamicin-collagen sponge and levofloxacin
• Levofloxacin only · Infectious Disease
  Inhibits DNA gyrase and topoisomerase IV

Phase 1 pipeline

• Marcaine 0.25% infiltration

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Innocoll portfolio CI brief
• Innocoll pipeline updates RSS